Skip to main content

Table 2 Demographic and baseline disease characteristics of the SSc patients

From: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis

  Overall (N = 88)
Age, years, mean (SD) 49 (13)
Female, N (%) 66 (75%)
White, N (%) 72 (82%)
Not Hispanic or Latino, N (%) 76 (86%)
Disease duration, years*, mean (SD) 1.59 (0.81)
Disease < 18 months, N (%) 53 (60%)
mRSS, mean (SD) 22.45 (7.65)
FVC% predicted, mean (SD) 85.4 (15.10)
DLCO% predicted, corrected for Hgb, mean (SD) 78.0 (18.24)
Patient global assessment, mean (SD) [theoretical range 0–10] 4.09 (2.38)
HAQ-DI, mean (SD) [theoretical range 0–3] 1.05 (0.71)
Physician global assessment, mean (SD) [theoretical range 0–10] 4.77 (1.67)
Tendon friction rubs, N (%) 32 (36%)
Large joint contractures, N (%) 63 (72%)
Swollen joint count, mean (SD) [theoretical range 0–28] 3.75 (5.70)
Proportion of participants with ≥ 1 swollen joint count, N (%) 42 (48%)
Previous use of immunosuppressives, N (%) 12 (14%)
Use of prednisone, N (%) 12 (14%)
  1. mRSS modified Rodnan skin score, FVC forced vital capacity, DLCO diffusion capacity of carbon monoxide
  2. *Disease onset was defined as the first non-Raynaud’s sign or symptoms